Sep. 11 at 5:42 PM
$AXSM Axsome rises as Mizuho highlights 'big month-over-month jump' for Auvelity
AXSM
1:04 PM
Mizuho analyst Graig Suvannavejh reports Bloomberg Symphony prescription data for the 30mg titration dose for Auvelity in ADA for the month of August pointed to new prescriptions and total prescriptions being up 32% and 34%, respectively, from July. "While still early days in the launch, this appears highly indicative of a strong start for Auvelity in ADA," wrote the analyst, who has an Outperform rating and
$316 price target on shares of Auvelity-maker Axsome Therapeutics. Shares of Axsome are up
$10.35, or 5% to
$221.46 in Friday afternoon trading.
